nodes	percent_of_prediction	percent_of_DWPC	metapath
Etravirine—ABCB1—Lisinopril—systemic scleroderma	0.113	0.191	CbGbCtD
Etravirine—CYP2C9—Leflunomide—systemic scleroderma	0.111	0.187	CbGbCtD
Etravirine—ABCB1—Captopril—systemic scleroderma	0.0844	0.143	CbGbCtD
Etravirine—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0664	0.112	CbGbCtD
Etravirine—CYP2C19—Prednisone—systemic scleroderma	0.0658	0.111	CbGbCtD
Etravirine—ABCB1—Prednisone—systemic scleroderma	0.0531	0.0898	CbGbCtD
Etravirine—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0398	0.0673	CbGbCtD
Etravirine—CYP3A4—Prednisone—systemic scleroderma	0.0318	0.0538	CbGbCtD
Etravirine—ABCB1—Methotrexate—systemic scleroderma	0.0266	0.045	CbGbCtD
Etravirine—CYP2C9—cardial valve—systemic scleroderma	0.0103	0.684	CbGeAlD
Etravirine—ABCB4—tendon—systemic scleroderma	0.00232	0.154	CbGeAlD
Etravirine—ABCB1—blood vessel—systemic scleroderma	0.000651	0.0431	CbGeAlD
Etravirine—CYP2C19—digestive system—systemic scleroderma	0.000576	0.0382	CbGeAlD
Etravirine—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.000467	0.00119	CcSEcCtD
Etravirine—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000467	0.00119	CcSEcCtD
Etravirine—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000463	0.00118	CcSEcCtD
Etravirine—Anorexia—Mycophenolic acid—systemic scleroderma	0.00046	0.00117	CcSEcCtD
Etravirine—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.00046	0.00117	CcSEcCtD
Etravirine—Tension—Mycophenolate mofetil—systemic scleroderma	0.000458	0.00116	CcSEcCtD
Etravirine—Insomnia—Leflunomide—systemic scleroderma	0.000458	0.00116	CcSEcCtD
Etravirine—Abdominal distension—Prednisone—systemic scleroderma	0.000457	0.00116	CcSEcCtD
Etravirine—Paraesthesia—Leflunomide—systemic scleroderma	0.000454	0.00116	CcSEcCtD
Etravirine—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.000453	0.00115	CcSEcCtD
Etravirine—Anxiety—Lisinopril—systemic scleroderma	0.000452	0.00115	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.00045	0.00115	CcSEcCtD
Etravirine—Discomfort—Lisinopril—systemic scleroderma	0.000448	0.00114	CcSEcCtD
Etravirine—CYP2C9—digestive system—systemic scleroderma	0.000447	0.0296	CbGeAlD
Etravirine—Pancreatitis—Prednisone—systemic scleroderma	0.000445	0.00113	CcSEcCtD
Etravirine—Vomiting—Mometasone—systemic scleroderma	0.000444	0.00113	CcSEcCtD
Etravirine—Dry mouth—Lisinopril—systemic scleroderma	0.000443	0.00113	CcSEcCtD
Etravirine—Feeling abnormal—Azathioprine—systemic scleroderma	0.000441	0.00112	CcSEcCtD
Etravirine—Rash—Mometasone—systemic scleroderma	0.000441	0.00112	CcSEcCtD
Etravirine—Asthenia—Captopril—systemic scleroderma	0.00044	0.00112	CcSEcCtD
Etravirine—Dermatitis—Mometasone—systemic scleroderma	0.00044	0.00112	CcSEcCtD
Etravirine—Decreased appetite—Leflunomide—systemic scleroderma	0.00044	0.00112	CcSEcCtD
Etravirine—Confusional state—Lisinopril—systemic scleroderma	0.000438	0.00111	CcSEcCtD
Etravirine—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000438	0.00111	CcSEcCtD
Etravirine—Headache—Mometasone—systemic scleroderma	0.000438	0.00111	CcSEcCtD
Etravirine—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000437	0.00111	CcSEcCtD
Etravirine—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000437	0.00111	CcSEcCtD
Etravirine—Insomnia—Mycophenolic acid—systemic scleroderma	0.000437	0.00111	CcSEcCtD
Etravirine—Fatigue—Leflunomide—systemic scleroderma	0.000436	0.00111	CcSEcCtD
Etravirine—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000433	0.0011	CcSEcCtD
Etravirine—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000433	0.0011	CcSEcCtD
Etravirine—Constipation—Leflunomide—systemic scleroderma	0.000433	0.0011	CcSEcCtD
Etravirine—Pain—Leflunomide—systemic scleroderma	0.000433	0.0011	CcSEcCtD
Etravirine—Infection—Lisinopril—systemic scleroderma	0.000432	0.0011	CcSEcCtD
Etravirine—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000431	0.0011	CcSEcCtD
Etravirine—Somnolence—Mycophenolic acid—systemic scleroderma	0.000429	0.00109	CcSEcCtD
Etravirine—Shock—Lisinopril—systemic scleroderma	0.000428	0.00109	CcSEcCtD
Etravirine—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000426	0.00108	CcSEcCtD
Etravirine—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000426	0.00108	CcSEcCtD
Etravirine—Abdominal pain—Azathioprine—systemic scleroderma	0.000423	0.00108	CcSEcCtD
Etravirine—Body temperature increased—Azathioprine—systemic scleroderma	0.000423	0.00108	CcSEcCtD
Etravirine—Skin disorder—Lisinopril—systemic scleroderma	0.000422	0.00107	CcSEcCtD
Etravirine—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000421	0.00107	CcSEcCtD
Etravirine—Hyperhidrosis—Lisinopril—systemic scleroderma	0.00042	0.00107	CcSEcCtD
Etravirine—Diarrhoea—Captopril—systemic scleroderma	0.00042	0.00107	CcSEcCtD
Etravirine—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.00042	0.00107	CcSEcCtD
Etravirine—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000419	0.00107	CcSEcCtD
Etravirine—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000419	0.00106	CcSEcCtD
Etravirine—Feeling abnormal—Leflunomide—systemic scleroderma	0.000417	0.00106	CcSEcCtD
Etravirine—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000417	0.00106	CcSEcCtD
Etravirine—Fatigue—Mycophenolic acid—systemic scleroderma	0.000416	0.00106	CcSEcCtD
Etravirine—Nausea—Mometasone—systemic scleroderma	0.000415	0.00106	CcSEcCtD
Etravirine—Anorexia—Lisinopril—systemic scleroderma	0.000414	0.00105	CcSEcCtD
Etravirine—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000414	0.00105	CcSEcCtD
Etravirine—Constipation—Mycophenolic acid—systemic scleroderma	0.000413	0.00105	CcSEcCtD
Etravirine—Pain—Mycophenolic acid—systemic scleroderma	0.000413	0.00105	CcSEcCtD
Etravirine—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.00041	0.00104	CcSEcCtD
Etravirine—Hyperglycaemia—Prednisone—systemic scleroderma	0.00041	0.00104	CcSEcCtD
Etravirine—Dizziness—Captopril—systemic scleroderma	0.000406	0.00103	CcSEcCtD
Etravirine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000404	0.00103	CcSEcCtD
Etravirine—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000403	0.00102	CcSEcCtD
Etravirine—Abdominal pain—Leflunomide—systemic scleroderma	0.0004	0.00102	CcSEcCtD
Etravirine—Body temperature increased—Leflunomide—systemic scleroderma	0.0004	0.00102	CcSEcCtD
Etravirine—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000399	0.00101	CcSEcCtD
Etravirine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000398	0.00101	CcSEcCtD
Etravirine—Myocardial infarction—Prednisone—systemic scleroderma	0.000397	0.00101	CcSEcCtD
Etravirine—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000397	0.00101	CcSEcCtD
Etravirine—Breast disorder—Methotrexate—systemic scleroderma	0.000397	0.00101	CcSEcCtD
Etravirine—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000396	0.00101	CcSEcCtD
Etravirine—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000395	0.00101	CcSEcCtD
Etravirine—Hypersensitivity—Azathioprine—systemic scleroderma	0.000395	0.001	CcSEcCtD
Etravirine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000395	0.001	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000395	0.001	CcSEcCtD
Etravirine—Insomnia—Lisinopril—systemic scleroderma	0.000393	0.001	CcSEcCtD
Etravirine—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000393	0.000998	CcSEcCtD
Etravirine—Paraesthesia—Lisinopril—systemic scleroderma	0.00039	0.000993	CcSEcCtD
Etravirine—Vomiting—Captopril—systemic scleroderma	0.00039	0.000992	CcSEcCtD
Etravirine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000389	0.000988	CcSEcCtD
Etravirine—Rash—Captopril—systemic scleroderma	0.000387	0.000984	CcSEcCtD
Etravirine—Dermatitis—Captopril—systemic scleroderma	0.000387	0.000983	CcSEcCtD
Etravirine—Somnolence—Lisinopril—systemic scleroderma	0.000386	0.000983	CcSEcCtD
Etravirine—Headache—Captopril—systemic scleroderma	0.000385	0.000978	CcSEcCtD
Etravirine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000384	0.000977	CcSEcCtD
Etravirine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000382	0.00097	CcSEcCtD
Etravirine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000382	0.00097	CcSEcCtD
Etravirine—Infection—Mycophenolate mofetil—systemic scleroderma	0.000378	0.000962	CcSEcCtD
Etravirine—Decreased appetite—Lisinopril—systemic scleroderma	0.000378	0.000961	CcSEcCtD
Etravirine—Eosinophilia—Methotrexate—systemic scleroderma	0.000376	0.000955	CcSEcCtD
Etravirine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000375	0.000954	CcSEcCtD
Etravirine—Fatigue—Lisinopril—systemic scleroderma	0.000375	0.000953	CcSEcCtD
Etravirine—Shock—Mycophenolate mofetil—systemic scleroderma	0.000375	0.000953	CcSEcCtD
Etravirine—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000374	0.00095	CcSEcCtD
Etravirine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000373	0.000948	CcSEcCtD
Etravirine—Hypersensitivity—Leflunomide—systemic scleroderma	0.000373	0.000948	CcSEcCtD
Etravirine—Pancreatitis—Methotrexate—systemic scleroderma	0.000372	0.000946	CcSEcCtD
Etravirine—Pain—Lisinopril—systemic scleroderma	0.000372	0.000945	CcSEcCtD
Etravirine—Constipation—Lisinopril—systemic scleroderma	0.000372	0.000945	CcSEcCtD
Etravirine—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.00037	0.000941	CcSEcCtD
Etravirine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000368	0.000936	CcSEcCtD
Etravirine—Diarrhoea—Azathioprine—systemic scleroderma	0.000367	0.000932	CcSEcCtD
Etravirine—Nausea—Captopril—systemic scleroderma	0.000365	0.000927	CcSEcCtD
Etravirine—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000363	0.000923	CcSEcCtD
Etravirine—Asthenia—Leflunomide—systemic scleroderma	0.000363	0.000923	CcSEcCtD
Etravirine—Feeling abnormal—Lisinopril—systemic scleroderma	0.000358	0.000911	CcSEcCtD
Etravirine—Connective tissue disorder—Prednisone—systemic scleroderma	0.000357	0.000908	CcSEcCtD
Etravirine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000355	0.000904	CcSEcCtD
Etravirine—Dizziness—Azathioprine—systemic scleroderma	0.000354	0.000901	CcSEcCtD
Etravirine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000346	0.000881	CcSEcCtD
Etravirine—Diarrhoea—Leflunomide—systemic scleroderma	0.000346	0.00088	CcSEcCtD
Etravirine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000344	0.000876	CcSEcCtD
Etravirine—Abdominal pain—Lisinopril—systemic scleroderma	0.000344	0.000874	CcSEcCtD
Etravirine—Body temperature increased—Lisinopril—systemic scleroderma	0.000344	0.000874	CcSEcCtD
Etravirine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000342	0.00087	CcSEcCtD
Etravirine—Vomiting—Azathioprine—systemic scleroderma	0.000341	0.000866	CcSEcCtD
Etravirine—CYP3A4—digestive system—systemic scleroderma	0.000341	0.0226	CbGeAlD
Etravirine—Eye disorder—Prednisone—systemic scleroderma	0.00034	0.000864	CcSEcCtD
Etravirine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000339	0.000861	CcSEcCtD
Etravirine—Rash—Azathioprine—systemic scleroderma	0.000338	0.000859	CcSEcCtD
Etravirine—Dermatitis—Azathioprine—systemic scleroderma	0.000337	0.000858	CcSEcCtD
Etravirine—Headache—Azathioprine—systemic scleroderma	0.000336	0.000853	CcSEcCtD
Etravirine—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000335	0.000853	CcSEcCtD
Etravirine—Dizziness—Leflunomide—systemic scleroderma	0.000335	0.000851	CcSEcCtD
Etravirine—Renal failure—Methotrexate—systemic scleroderma	0.000333	0.000846	CcSEcCtD
Etravirine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000331	0.000842	CcSEcCtD
Etravirine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00033	0.00084	CcSEcCtD
Etravirine—Stomatitis—Methotrexate—systemic scleroderma	0.00033	0.000839	CcSEcCtD
Etravirine—Angiopathy—Prednisone—systemic scleroderma	0.00033	0.000838	CcSEcCtD
Etravirine—Conjunctivitis—Methotrexate—systemic scleroderma	0.000329	0.000836	CcSEcCtD
Etravirine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000329	0.000836	CcSEcCtD
Etravirine—Immune system disorder—Prednisone—systemic scleroderma	0.000328	0.000835	CcSEcCtD
Etravirine—Pain—Mycophenolate mofetil—systemic scleroderma	0.000326	0.000828	CcSEcCtD
Etravirine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000326	0.000828	CcSEcCtD
Etravirine—Vomiting—Leflunomide—systemic scleroderma	0.000322	0.000818	CcSEcCtD
Etravirine—Hypersensitivity—Lisinopril—systemic scleroderma	0.00032	0.000814	CcSEcCtD
Etravirine—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.00032	0.000814	CcSEcCtD
Etravirine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000319	0.000812	CcSEcCtD
Etravirine—Rash—Leflunomide—systemic scleroderma	0.000319	0.000811	CcSEcCtD
Etravirine—Dermatitis—Leflunomide—systemic scleroderma	0.000319	0.00081	CcSEcCtD
Etravirine—Mental disorder—Prednisone—systemic scleroderma	0.000318	0.00081	CcSEcCtD
Etravirine—Nausea—Azathioprine—systemic scleroderma	0.000318	0.000809	CcSEcCtD
Etravirine—Headache—Leflunomide—systemic scleroderma	0.000317	0.000806	CcSEcCtD
Etravirine—Malnutrition—Prednisone—systemic scleroderma	0.000316	0.000804	CcSEcCtD
Etravirine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000314	0.000798	CcSEcCtD
Etravirine—Asthenia—Lisinopril—systemic scleroderma	0.000312	0.000793	CcSEcCtD
Etravirine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000311	0.000792	CcSEcCtD
Etravirine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000307	0.00078	CcSEcCtD
Etravirine—Rash—Mycophenolic acid—systemic scleroderma	0.000304	0.000774	CcSEcCtD
Etravirine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000304	0.000773	CcSEcCtD
Etravirine—Hepatitis—Methotrexate—systemic scleroderma	0.000304	0.000772	CcSEcCtD
Etravirine—Headache—Mycophenolic acid—systemic scleroderma	0.000302	0.000769	CcSEcCtD
Etravirine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000301	0.000766	CcSEcCtD
Etravirine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000301	0.000766	CcSEcCtD
Etravirine—Nausea—Leflunomide—systemic scleroderma	0.000301	0.000764	CcSEcCtD
Etravirine—Urinary tract disorder—Methotrexate—systemic scleroderma	0.0003	0.000763	CcSEcCtD
Etravirine—Vision blurred—Prednisone—systemic scleroderma	0.000298	0.000758	CcSEcCtD
Etravirine—Urethral disorder—Methotrexate—systemic scleroderma	0.000298	0.000757	CcSEcCtD
Etravirine—Diarrhoea—Lisinopril—systemic scleroderma	0.000297	0.000756	CcSEcCtD
Etravirine—Ill-defined disorder—Prednisone—systemic scleroderma	0.000294	0.000746	CcSEcCtD
Etravirine—Anaemia—Prednisone—systemic scleroderma	0.000292	0.000743	CcSEcCtD
Etravirine—Angioedema—Prednisone—systemic scleroderma	0.000289	0.000735	CcSEcCtD
Etravirine—Dizziness—Lisinopril—systemic scleroderma	0.000287	0.000731	CcSEcCtD
Etravirine—Erythema multiforme—Methotrexate—systemic scleroderma	0.000287	0.00073	CcSEcCtD
Etravirine—Nausea—Mycophenolic acid—systemic scleroderma	0.000287	0.000729	CcSEcCtD
Etravirine—Malaise—Prednisone—systemic scleroderma	0.000285	0.000725	CcSEcCtD
Etravirine—Vertigo—Prednisone—systemic scleroderma	0.000284	0.000723	CcSEcCtD
Etravirine—Eye disorder—Methotrexate—systemic scleroderma	0.000284	0.000722	CcSEcCtD
Etravirine—Syncope—Prednisone—systemic scleroderma	0.000284	0.000721	CcSEcCtD
Etravirine—Cardiac disorder—Methotrexate—systemic scleroderma	0.000282	0.000717	CcSEcCtD
Etravirine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000281	0.000714	CcSEcCtD
Etravirine—Loss of consciousness—Prednisone—systemic scleroderma	0.000278	0.000707	CcSEcCtD
Etravirine—Vomiting—Lisinopril—systemic scleroderma	0.000276	0.000703	CcSEcCtD
Etravirine—Angiopathy—Methotrexate—systemic scleroderma	0.000276	0.000701	CcSEcCtD
Etravirine—Immune system disorder—Methotrexate—systemic scleroderma	0.000274	0.000698	CcSEcCtD
Etravirine—Rash—Lisinopril—systemic scleroderma	0.000274	0.000697	CcSEcCtD
Etravirine—Convulsion—Prednisone—systemic scleroderma	0.000274	0.000697	CcSEcCtD
Etravirine—Dermatitis—Lisinopril—systemic scleroderma	0.000274	0.000696	CcSEcCtD
Etravirine—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000274	0.000696	CcSEcCtD
Etravirine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000273	0.000695	CcSEcCtD
Etravirine—Hypertension—Prednisone—systemic scleroderma	0.000273	0.000694	CcSEcCtD
Etravirine—Headache—Lisinopril—systemic scleroderma	0.000272	0.000692	CcSEcCtD
Etravirine—Anxiety—Prednisone—systemic scleroderma	0.000268	0.000682	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000267	0.00068	CcSEcCtD
Etravirine—Discomfort—Prednisone—systemic scleroderma	0.000266	0.000677	CcSEcCtD
Etravirine—Mental disorder—Methotrexate—systemic scleroderma	0.000266	0.000677	CcSEcCtD
Etravirine—Malnutrition—Methotrexate—systemic scleroderma	0.000264	0.000672	CcSEcCtD
Etravirine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000261	0.000663	CcSEcCtD
Etravirine—Nausea—Lisinopril—systemic scleroderma	0.000258	0.000657	CcSEcCtD
Etravirine—Infection—Prednisone—systemic scleroderma	0.000256	0.000652	CcSEcCtD
Etravirine—Shock—Prednisone—systemic scleroderma	0.000254	0.000646	CcSEcCtD
Etravirine—Nervous system disorder—Prednisone—systemic scleroderma	0.000253	0.000644	CcSEcCtD
Etravirine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000252	0.00064	CcSEcCtD
Etravirine—Skin disorder—Prednisone—systemic scleroderma	0.000251	0.000638	CcSEcCtD
Etravirine—Hyperhidrosis—Prednisone—systemic scleroderma	0.00025	0.000635	CcSEcCtD
Etravirine—Vision blurred—Methotrexate—systemic scleroderma	0.000249	0.000634	CcSEcCtD
Etravirine—Anorexia—Prednisone—systemic scleroderma	0.000246	0.000626	CcSEcCtD
Etravirine—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000245	0.000624	CcSEcCtD
Etravirine—Anaemia—Methotrexate—systemic scleroderma	0.000244	0.000621	CcSEcCtD
Etravirine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000242	0.000616	CcSEcCtD
Etravirine—ABCB1—digestive system—systemic scleroderma	0.000241	0.016	CbGeAlD
Etravirine—Rash—Mycophenolate mofetil—systemic scleroderma	0.00024	0.000611	CcSEcCtD
Etravirine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00024	0.00061	CcSEcCtD
Etravirine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000239	0.000607	CcSEcCtD
Etravirine—Malaise—Methotrexate—systemic scleroderma	0.000238	0.000606	CcSEcCtD
Etravirine—Vertigo—Methotrexate—systemic scleroderma	0.000238	0.000604	CcSEcCtD
Etravirine—Insomnia—Prednisone—systemic scleroderma	0.000234	0.000594	CcSEcCtD
Etravirine—Paraesthesia—Prednisone—systemic scleroderma	0.000232	0.00059	CcSEcCtD
Etravirine—Convulsion—Methotrexate—systemic scleroderma	0.000229	0.000582	CcSEcCtD
Etravirine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000226	0.000575	CcSEcCtD
Etravirine—Decreased appetite—Prednisone—systemic scleroderma	0.000224	0.000571	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000224	0.000568	CcSEcCtD
Etravirine—Fatigue—Prednisone—systemic scleroderma	0.000223	0.000566	CcSEcCtD
Etravirine—Discomfort—Methotrexate—systemic scleroderma	0.000222	0.000565	CcSEcCtD
Etravirine—Constipation—Prednisone—systemic scleroderma	0.000221	0.000561	CcSEcCtD
Etravirine—Confusional state—Methotrexate—systemic scleroderma	0.000218	0.000553	CcSEcCtD
Etravirine—Infection—Methotrexate—systemic scleroderma	0.000214	0.000545	CcSEcCtD
Etravirine—Feeling abnormal—Prednisone—systemic scleroderma	0.000213	0.000541	CcSEcCtD
Etravirine—Nervous system disorder—Methotrexate—systemic scleroderma	0.000212	0.000538	CcSEcCtD
Etravirine—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000211	0.000537	CcSEcCtD
Etravirine—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000211	0.000537	CcSEcCtD
Etravirine—Skin disorder—Methotrexate—systemic scleroderma	0.00021	0.000533	CcSEcCtD
Etravirine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000209	0.00053	CcSEcCtD
Etravirine—Anorexia—Methotrexate—systemic scleroderma	0.000206	0.000523	CcSEcCtD
Etravirine—Body temperature increased—Prednisone—systemic scleroderma	0.000204	0.000519	CcSEcCtD
Etravirine—Abdominal pain—Prednisone—systemic scleroderma	0.000204	0.000519	CcSEcCtD
Etravirine—ABCB1—lung—systemic scleroderma	0.000201	0.0133	CbGeAlD
Etravirine—Insomnia—Methotrexate—systemic scleroderma	0.000195	0.000496	CcSEcCtD
Etravirine—Paraesthesia—Methotrexate—systemic scleroderma	0.000194	0.000493	CcSEcCtD
Etravirine—Somnolence—Methotrexate—systemic scleroderma	0.000192	0.000488	CcSEcCtD
Etravirine—Hypersensitivity—Prednisone—systemic scleroderma	0.00019	0.000484	CcSEcCtD
Etravirine—Decreased appetite—Methotrexate—systemic scleroderma	0.000188	0.000477	CcSEcCtD
Etravirine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000186	0.000474	CcSEcCtD
Etravirine—Fatigue—Methotrexate—systemic scleroderma	0.000186	0.000473	CcSEcCtD
Etravirine—Asthenia—Prednisone—systemic scleroderma	0.000185	0.000471	CcSEcCtD
Etravirine—Pain—Methotrexate—systemic scleroderma	0.000185	0.000469	CcSEcCtD
Etravirine—Feeling abnormal—Methotrexate—systemic scleroderma	0.000178	0.000452	CcSEcCtD
Etravirine—Diarrhoea—Prednisone—systemic scleroderma	0.000177	0.000449	CcSEcCtD
Etravirine—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000176	0.000449	CcSEcCtD
Etravirine—Dizziness—Prednisone—systemic scleroderma	0.000171	0.000434	CcSEcCtD
Etravirine—Body temperature increased—Methotrexate—systemic scleroderma	0.000171	0.000434	CcSEcCtD
Etravirine—Abdominal pain—Methotrexate—systemic scleroderma	0.000171	0.000434	CcSEcCtD
Etravirine—Vomiting—Prednisone—systemic scleroderma	0.000164	0.000417	CcSEcCtD
Etravirine—Rash—Prednisone—systemic scleroderma	0.000163	0.000414	CcSEcCtD
Etravirine—Dermatitis—Prednisone—systemic scleroderma	0.000163	0.000414	CcSEcCtD
Etravirine—Headache—Prednisone—systemic scleroderma	0.000162	0.000411	CcSEcCtD
Etravirine—Hypersensitivity—Methotrexate—systemic scleroderma	0.000159	0.000404	CcSEcCtD
Etravirine—Asthenia—Methotrexate—systemic scleroderma	0.000155	0.000394	CcSEcCtD
Etravirine—Nausea—Prednisone—systemic scleroderma	0.000153	0.00039	CcSEcCtD
Etravirine—Diarrhoea—Methotrexate—systemic scleroderma	0.000148	0.000375	CcSEcCtD
Etravirine—Dizziness—Methotrexate—systemic scleroderma	0.000143	0.000363	CcSEcCtD
Etravirine—Vomiting—Methotrexate—systemic scleroderma	0.000137	0.000349	CcSEcCtD
Etravirine—Rash—Methotrexate—systemic scleroderma	0.000136	0.000346	CcSEcCtD
Etravirine—Dermatitis—Methotrexate—systemic scleroderma	0.000136	0.000346	CcSEcCtD
Etravirine—Headache—Methotrexate—systemic scleroderma	0.000135	0.000344	CcSEcCtD
Etravirine—Nausea—Methotrexate—systemic scleroderma	0.000128	0.000326	CcSEcCtD
